Cargando…
Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
PURPOSE: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the preval...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611264/ https://www.ncbi.nlm.nih.gov/pubmed/31238427 http://dx.doi.org/10.4103/ijo.IJO_1533_18 |
_version_ | 1783432660064927744 |
---|---|
author | Satgunam, PremNandhini Sumalini, Rebecca Chittapu, Gayathri Pamarthi, Gunasree |
author_facet | Satgunam, PremNandhini Sumalini, Rebecca Chittapu, Gayathri Pamarthi, Gunasree |
author_sort | Satgunam, PremNandhini |
collection | PubMed |
description | PURPOSE: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the prevalence for CBS in India is largely unknown. The primary aim of this study was to estimate CBS prevalence in patients with vision impairment visiting a tertiary eye care center. METHODS: The study was conducted in two phases. In phase 1, patients with VI, age ≥40 years with presenting visual acuity worse than 20/63 were enrolled. In phase 2, patients with presenting visual acuity worse than 20/63 and/or with binocular visual field loss, age ≥18 years were recruited. A CBS survey was administered only to those who passed a screening test for cognition impairment. RESULTS: A total of 218 patients were screened (phase 1 = 113 and phase 2 = 105). Two-hundred ten patients (mean age ± standard deviation = 49.2 ± 17.3 years, males = 139) were found eligible to complete the CBS survey. Fourteen patients were found to have visual hallucinations. In addition, three other patients had visual hallucinations with associated auditory input to the visual imagery. All patients had complete insight about their hallucinations. CONCLUSION: Depending on the inclusion criteria, we found the prevalence for CBS in patients with VI to vary between 6.7% to 8.1% (if including patients with auditory input). More investigation is needed to assess the associated role of other sensory inputs (e.g. auditory) with the visual imagery experienced in CBS. |
format | Online Article Text |
id | pubmed-6611264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-66112642019-07-22 Screening for Charles Bonnet syndrome: Should the definition be reconsidered? Satgunam, PremNandhini Sumalini, Rebecca Chittapu, Gayathri Pamarthi, Gunasree Indian J Ophthalmol Original Article PURPOSE: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the prevalence for CBS in India is largely unknown. The primary aim of this study was to estimate CBS prevalence in patients with vision impairment visiting a tertiary eye care center. METHODS: The study was conducted in two phases. In phase 1, patients with VI, age ≥40 years with presenting visual acuity worse than 20/63 were enrolled. In phase 2, patients with presenting visual acuity worse than 20/63 and/or with binocular visual field loss, age ≥18 years were recruited. A CBS survey was administered only to those who passed a screening test for cognition impairment. RESULTS: A total of 218 patients were screened (phase 1 = 113 and phase 2 = 105). Two-hundred ten patients (mean age ± standard deviation = 49.2 ± 17.3 years, males = 139) were found eligible to complete the CBS survey. Fourteen patients were found to have visual hallucinations. In addition, three other patients had visual hallucinations with associated auditory input to the visual imagery. All patients had complete insight about their hallucinations. CONCLUSION: Depending on the inclusion criteria, we found the prevalence for CBS in patients with VI to vary between 6.7% to 8.1% (if including patients with auditory input). More investigation is needed to assess the associated role of other sensory inputs (e.g. auditory) with the visual imagery experienced in CBS. Wolters Kluwer - Medknow 2019-07 /pmc/articles/PMC6611264/ /pubmed/31238427 http://dx.doi.org/10.4103/ijo.IJO_1533_18 Text en Copyright: © 2019 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Satgunam, PremNandhini Sumalini, Rebecca Chittapu, Gayathri Pamarthi, Gunasree Screening for Charles Bonnet syndrome: Should the definition be reconsidered? |
title | Screening for Charles Bonnet syndrome: Should the definition be reconsidered? |
title_full | Screening for Charles Bonnet syndrome: Should the definition be reconsidered? |
title_fullStr | Screening for Charles Bonnet syndrome: Should the definition be reconsidered? |
title_full_unstemmed | Screening for Charles Bonnet syndrome: Should the definition be reconsidered? |
title_short | Screening for Charles Bonnet syndrome: Should the definition be reconsidered? |
title_sort | screening for charles bonnet syndrome: should the definition be reconsidered? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611264/ https://www.ncbi.nlm.nih.gov/pubmed/31238427 http://dx.doi.org/10.4103/ijo.IJO_1533_18 |
work_keys_str_mv | AT satgunampremnandhini screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered AT sumalinirebecca screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered AT chittapugayathri screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered AT pamarthigunasree screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered |